Bibliographic Details
| Title: |
Efficacy and safety of iris-supported phakic lenses (Verisyse) for treating moderately high myopia. |
| Alternate Title: |
Efikasnost i sigurnost iris-fiksirajućih fakičnih leća (Verisyse) za tretman srednjevisoke miopije. |
| Authors: |
Pjano, Melisa Ahmedbegović1 melisa@svjetlost-sarajevo.ba, Alikadić-Husović, Amila1, Grišević, Senad1, Pašalić, Adis2, Pidro, Ajla1, Ratković, Mirko2, Bohač, Maja2, Gabrić, Nikica2, Gojak, Refet3 |
| Source: |
Medicinski Glasnik. Feb2016, Vol. 13 Issue 1, p25-30. 6p. |
| Subject Terms: |
*MYOPIA treatment, *TREATMENT effectiveness, *ASTIGMATISM (Optics), *INTRAOCULAR pressure, *VISUAL acuity, *ENDOTHELIAL cells |
| Abstract (English): |
Aim To evaluate efficacy and safety of iris-supported phakic lenses (Verisyse) for treating moderately high myopia. Methods This prospective clinical study included 40 eyes from 29 patients, who underwent implantation of Verisyse for correction of myopia from -6.00 to -14.50 diopters (D) in the Eye Clinic ''Svjetlost'', Sarajevo, from January 2011 to January 2014. Uncorrected distance visual acuity (UDVA), manifest residual spherical equivalent (MRSE), postoperative astigmatism, intraocular pressure (IOP), endothelial cell (EC) density were evaluated at one, three, six and twelve months. Corrected visual acuity (CDVA), index of safety and efficacy were evaluated after 12 months. Results Out of 29 patients 15 were males and 14 females, with mean age of 27.9 ± 5.0. After 12 months 77.5% eyes had UDVA = 0.5 and 32.5% had UDVA = 0.8. Mean MRSE was 0.55D ± 0.57D and mean postoperative astigmatism -0.86D ± 0.47D. Efficacy index was 1.09 ± 0.19 and safety index 1.18 ± 0.21. One eye (2.5%) lost two Snellen lines and three eyes (7.5%) one line, 11 eyes (27.5%) gained one line, and five eyes (15.5%) gained two lines. EC loss after 12 months was 7.59 ± 3.05%. There was no significant change of IOP after one year follow up. Conclusion Implantation of iris-supported phakic lenses (Verisyse) for treating moderately high myopia is an efficient and safe procedure. [ABSTRACT FROM AUTHOR] |
| Abstract (Croatian): |
Cilj Evaluirati efikasnost i sigurnost iris-fiksirajućih fakičnih leća (Verisyse) za tretman srednje visoke miopije. Metode Prospektivna klinička studija obuhvatila je 40 očiju od 29 pacijenata koji su bili podvrgnuti implantaciji Verisyse lećâ, zbog korekcije miopije u iznosu od -6.00 D do -14.00 D, u Poliklinici "Svjetlost" Sarajevo, od januara 2011. do januara 2014. godine. Nekorigovana vidna oštrina za daljinu (UDVA), manifestni rezidualni sferni ekvivalent (MRSE), postoperativni astigmatizam, intraokularni pritisak (IOP) te gustoća endotelnih ćelija (EC) evaluirani su na jedan, tri, šest i 12 mjeseci. Korigovana vidna oštrina (CDVA), indeks sigurnosti i efikasnosti evaluirani su nakon 12 mjeseci. Rezultati Od 29 pacijenata 15 su bili muškarci, a 14 žene, sa srednjom vrijednosti godina 27,9 (±5,0). Nakon 12 mjeseci 77,5% očiju imali su UDVA = 0.5, a 32,5% je imalo UDVA = 0.8. Srednja vrijednost MRSE bila je 0,55 D ± 0,57 D, a srednja vrijednost postoperativnog astigmatizma bila je -0,86 D ± 0,47 D. Indeks efikasnosti je iznosio 1,09 ± 0,19 a indeks sigurnosti 1,18 ± 0,21. Jedno oko (2,5%) je izgubilo dvije Snellenove linije, a tri oka (7,5%) jednu liniju; 11 očiju (27,5%) je dobilo jednu liniju, a pet očiju (15,5%) dobilo je dvije linije. Gubitak endotelnih ćelija, nakon 12 mjeseci, iznosio je 7,59 ± 3,05%. Nije bilo statistički značajne promjene u visini očnog pritiska u toku perioda praćenja. Zaključak Implantacija iris-fiksirajućih fakičnih leća (Verisyse) je efikasna i sigurna metoda za tretman srednje visoke miopije. [ABSTRACT FROM AUTHOR] |
|
Copyright of Medicinski Glasnik is the property of Medical Association of Zenica-Doboj Canton (Ljekarska Komora Ze-Do Kantona) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
